Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mingyi Ju

5PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Aug 01, 2024
Prophylactic IL-23 blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Mingyi Ju, Jiaojiao Zhang, Zhuoyuan Deng

|Oct 17, 2023
Advancement of anti-LAG-3 in cancer therapy.

Yunong Li, Mingyi Ju, Yuxi Miao

|Oct 28, 2021
A Immune-Related Signature Associated with TME Can Serve as a Potential Biomarker for Survival and Sorafenib Resistance in Liver Cancer.

Mingyi Ju, Longyang Jiang, Qian Wei

|Nov 19, 2020
Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer.

Mingyi Ju, Jia Bi, Qian Wei

|Apr 20, 2020
A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.

Mingyi Ju, Aoshuang Qi, Jia Bi

Pageof 1

Frequent Collaborators

1 joint publications

Yunong Li

1 joint publications

Yuxi Miao

1 joint publications

Lin Zhao

1 joint publications

Lijuan Xing

1 joint publications

Minjie Wei

1 joint publications

Lianghua Ma

Frequent Collaborators

1 joint publications

Yunong Li

1 joint publications

Yuxi Miao

1 joint publications

Lin Zhao

1 joint publications

Lijuan Xing

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

8.9K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.4K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.8K
See more related videos

Top Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

8.9K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

3.4K
Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of <em>TMEM200A</em> as a Pan-Cancer Biomarker

Published on : Sep 15, 2023

1.8K
See more related videos